Teva
- "Teva Ramps Up R&D Spending to Fuel Growth—Analysts Get It"
Stock Drops 13% as 2025 Guidance Disappoints, but Management Stands by Long-Term Strategy; An interview with Teva's CFO, Eli Kalif
Interview
Stock Drops 13% as 2025 Guidance Disappoints, but Management Stands by Long-Term Strategy; An interview with Teva's CFO, Eli Kalif
Interview